Page last updated: 2024-11-02

pargyline and Hypertrophy

pargyline has been researched along with Hypertrophy in 1 studies

Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.

Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bianchi, P1
Pimentel, DR1
Murphy, MP1
Colucci, WS1
Parini, A1

Other Studies

1 other study available for pargyline and Hypertrophy

ArticleYear
A new hypertrophic mechanism of serotonin in cardiac myocytes: receptor-independent ROS generation.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2005, Volume: 19, Issue:6

    Topics: Adrenergic Uptake Inhibitors; Animals; Catalase; Cells, Cultured; Enzyme Activation; Flavonoids; Gen

2005